ITM vs EQT22 Oct 2020 22:27
When I last checked EQT had £10m in the bank, projected sales for 2021 of around £40m, proven technology, and near term profitable (projected within 2022), commercial tenders for H1 returned over €200m and growing into H2 2020.
Now look at ITM annual results
FY2020 Financials:
· Transition year with revenues and EBITDA adversely affected by COVID-19, Brexit and the adoption of IFRS 15
· Total Revenue & Project Grant Funding of £5.4m (2019: £17.5m) down 69%, comprising:
o Sales revenue: £3.3m (2019: £4.6m) down 28%
o Collaborative grant income recognised: £2.1m (2019: £12.9m) down 84%
· Loss from operations £29.4m (2019: £9.3m),
· Adjusted EBITDA loss (see note 7) £18.1m (2019: loss £7.3m), increased 148%
· Available cash balance of £39.9m at year-end (2019: £5.2m)
Sales revenue not too dissimilar to EQT, cash balance is 4 x EQT, pipeline is less than EQT by approx 50% and an annual loss of £29m suggests that they are not even close to profit.
Now for the good bit
EQT MCap is £34m vs ITM MCal £1.2bn
That is 30 x that of EQT